Quantitative analysis confirmed that MBP immunofluorescence intensity was significantly less in 6-month 3xTg-AD hippocampus compared to age-matched non-Tg controls (Fig. 1Bv; p < 0.001) and equivalent to the level seen in 24-month controls. This evidence concerns the gene MBP and Alzheimer disease.